Screening average-risk populations for colorectal cancer can reduce the incidence and mortality of colorectal cancer. Effectiveness depends on programmatic adherence and quality. This review discusses the evidence supporting the use of currently available screening tests. The discussion specifically focuses on programmatic issues and highlights the importance of quality assurance in each program.
- Colorectal cancer
- Computed tomographic colonography
- Fecal occult blood test
ASJC Scopus subject areas